MCL Healing: Interdisciplinary Studies
MCL 治疗:跨学科研究
基本信息
- 批准号:6766696
- 负责人:
- 金额:$ 41.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-07-20 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:arthroplastybiomechanicsbiotechnologycollagencombination chemotherapygene therapygoatsjoint ligamentkneelaboratory rabbitlight microscopylongitudinal animal studymedical rehabilitation related tagmusculoskeletal disorder therapymusculoskeletal injurynonhuman therapy evaluationpolymerase chain reactiontensile strengthtissue /cell culturetissue engineeringtissue support frametransmission electron microscopywestern blottingswound healing
项目摘要
DESCRIPTION (provided by applicant): Injuries to knee ligaments are becoming
more frequent and more extensive, demanding increased understanding of the
healing process and methods to enhance it. Clinically, the injured medial
collateral ligament (MCL) has been found to heal without surgical intervention;
however, laboratory studies have shown that the quality of the healed tissue
remains far from the normal tissue, even after one year. There are serious
concerns about the suboptimal biomechanical, biochemical, and
histomorphological properties of healing tissue, especially in the case of more
severe injuries that involve both the MCL and anterior cruciate ligament (ACL),
which may lead to the early development of osteoarthritis. There is yet no
consensus of opinion on the therapeutic approach to such combined MCL/ACL
injuries. New and innovative approaches, such as antisense gene therapy and
functional tissue engineering, have become available. Thus, the overall
objective of this study is to explore novel ways to enhance MCL healing. The
proposed study involves four Specific Aims: (1) antisense oligodeoxynucleotides
(ODNs) specific for collagen types V and III, alone and in combination, will be
delivered to the healing MCL to reduce the ratios of collagen types V/I and
III/I, thereby increasing the collagen fibril diameter; (2) a tissue-engineered
small intestinal submucosa (SIS) scaffold will be applied to aid the healing
MCL after rupture by improving the collagen fiber alignment; (3) the optimal
treatments from above will be applied concurrently to further enhance the
healing process; and (4) this treatment modality will be extended to improve
MCL healing in the more severe combined MCL/ACL injury.
Using an interdisciplinary approach, the biomechanical, biochemical, and
histomorphological properties of the healing MCL will be evaluated.
Biomechanical testing will assess joint instability, as well as the tensile and
viscoelastic behaviors of the healing MCL. Biochemical analysis will include
determination of collagen and proteoglycan contents, as well as typing of
collagen and collagen crosslinking. Histomorphological analysis will measure
the changes in collagen fibril diameter and fiber alignment. It is anticipated
that increasing the diameter of collagen fibril and improving collagen fiber
alignment of the healing MCL will lead to improved biomechanical properties,
thereby enhancing the quality of the healing tissue. The knowledge gained from
this study will enhance the understanding of the mechanisms of ligament
healing, which in turn, could be applied to aid in the healing of other
ligaments (ACL) and tendons (flexor tendon).
描述(由申请人提供):膝关节韧带损伤正在变得越来越严重
更频繁、更广泛,要求加深对
愈合过程和增强它的方法。临床上,受伤的内侧
研究发现,副韧带 (MCL) 无需手术干预即可愈合;
然而,实验室研究表明,愈合组织的质量
即使一年后,仍然远离正常组织。有严重的
对次优生物力学、生化和
愈合组织的组织形态学特性,特别是在更多的情况下
涉及 MCL 和前十字韧带 (ACL) 的严重损伤,
这可能会导致骨关节炎的早期发展。目前还没有
此类合并MCL/ACL的治疗方法达成共识
受伤。新的和创新的方法,例如反义基因疗法和
功能性组织工程已成为现实。因此,总体
本研究的目的是探索增强 MCL 愈合的新方法。这
拟议的研究涉及四个具体目标:(1)反义寡脱氧核苷酸
(ODN) 特异性针对 V 型和 III 型胶原蛋白,单独或组合,将
输送至正在愈合的 MCL,以降低 V/I 型胶原蛋白的比例,
III/I,从而增加胶原原纤维直径; (2)组织工程
将应用小肠粘膜下层 (SIS) 支架来帮助愈合
MCL破裂后通过改善胶原纤维排列; (3)最优
上述治疗方法将同时应用,以进一步增强
愈合过程; (4) 这种治疗方式将得到推广,以改善
更严重的 MCL/ACL 联合损伤中的 MCL 愈合。
采用跨学科方法,生物力学、生物化学和
将评估愈合中 MCL 的组织形态学特性。
生物力学测试将评估关节的不稳定性以及拉伸和
愈合中 MCL 的粘弹性行为。生化分析将包括
胶原蛋白和蛋白多糖含量的测定,以及分型
胶原蛋白和胶原蛋白交联。组织形态学分析将测量
胶原纤维直径和纤维排列的变化。预计
增加胶原纤维直径,改善胶原纤维
愈合中的 MCL 的对齐将导致生物力学特性的改善,
从而提高愈合组织的质量。所获得的知识来自
这项研究将增强对韧带机制的理解
治愈,反过来又可以用来帮助治愈其他人
韧带(ACL)和肌腱(屈肌腱)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAVIO L-Y. WOO其他文献
SAVIO L-Y. WOO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAVIO L-Y. WOO', 18)}}的其他基金
HEALING OF THE MCL--INTERDISCIPLINARY STUDIES
内侧副韧带的治愈——跨学科研究
- 批准号:
2732850 - 财政年份:1993
- 资助金额:
$ 41.84万 - 项目类别:
相似海外基金
Innovative medical device to treat nonunion fracture for older adults
治疗老年人骨折不愈合的创新医疗设备
- 批准号:
10766444 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
Bioengineered Tissues For Uterine Reconstruction
用于子宫重建的生物工程组织
- 批准号:
10420259 - 财政年份:2022
- 资助金额:
$ 41.84万 - 项目类别:
Bioengineered Tissues For Uterine Reconstruction
用于子宫重建的生物工程组织
- 批准号:
10582724 - 财政年份:2022
- 资助金额:
$ 41.84万 - 项目类别:
Lung fibrosis modeling and compound testing platform using fibrotic lung ECM that recreates the fibrotic disease environment to improve predictiveness and accelerate anti-fibrotic drug development
使用纤维化肺 ECM 的肺纤维化建模和复合测试平台,可重建纤维化疾病环境,以提高预测性并加速抗纤维化药物的开发
- 批准号:
10515017 - 财政年份:2021
- 资助金额:
$ 41.84万 - 项目类别:
Delaware Center for Musculoskeletal Research – Multiscale Assessments Research Core
特拉华州肌肉骨骼研究中心 — 多尺度评估研究核心
- 批准号:
10091021 - 财政年份:2021
- 资助金额:
$ 41.84万 - 项目类别:
Delaware Center for Musculoskeletal Research – Multiscale Assessments Research Core
特拉华州肌肉骨骼研究中心 — 多尺度评估研究核心
- 批准号:
10569531 - 财政年份:2021
- 资助金额:
$ 41.84万 - 项目类别:
Lung fibrosis modeling and compound testing platform using fibrotic lung ECM that recreates the fibrotic disease environment to improve predictiveness and accelerate anti-fibrotic drug development
使用纤维化肺 ECM 的肺纤维化建模和复合测试平台,可重建纤维化疾病环境,以提高预测性并加速抗纤维化药物的开发
- 批准号:
10793211 - 财政年份:2021
- 资助金额:
$ 41.84万 - 项目类别:
Delaware Center for Musculoskeletal Research – Multiscale Assessments Research Core
特拉华州肌肉骨骼研究中心 — 多尺度评估研究核心
- 批准号:
10352303 - 财政年份:2021
- 资助金额:
$ 41.84万 - 项目类别:
Lung fibrosis modeling and compound testing platform using fibrotic lung ECM that recreates the fibrotic disease environment to improve predictiveness and accelerate anti-fibrotic drug development
使用纤维化肺 ECM 的肺纤维化建模和复合测试平台,可重建纤维化疾病环境,以提高预测性并加速抗纤维化药物的开发
- 批准号:
10609532 - 财政年份:2021
- 资助金额:
$ 41.84万 - 项目类别:
Lung fibrosis modeling and compound testing platform using fibrotic lung ECM that recreates the fibrotic disease environment to improve predictiveness and accelerate anti-fibrotic drug development
使用纤维化肺 ECM 的肺纤维化建模和复合测试平台,可重建纤维化疾病环境,以提高预测性并加速抗纤维化药物的开发
- 批准号:
10323494 - 财政年份:2021
- 资助金额:
$ 41.84万 - 项目类别: